nad+ and ghk cu together 🔋 + GHK-Cu ✨ One could support cellular energy + longevity… the other could support repair, collagen + glow. Both could be the ultimate inside-out upgrade. Because looking better is cute… nad and ghk-cu NAD+ vs

Special care is required when using the drug There are no special precautions required

Apply ice two to three times daily for 15 to 20 minutes if you experience mild swelling

I am grateful to have discovered Intravenous Solutions today

in vitro growth hormone secretion assays Cell lines Somatotroph cell cultures for mechanistic receptor studies Research Limitations & Regulatory Status Critical Gaps in Current Evidence Despite over two decades of preclinical investigation and limited early-phase human studies, the CJC-1295 (NO DAC) + Ipamorelin blend faces substantial evidence gaps that prevent clinical application: Lack of Human Clinical Data The most significant limitation is the absence of completed, peer-reviewed Phase III clinical trials: No FDA-approved indications for either peptide individually or in combination Phase II trials discontinued for CJC-1295 DAC following death of trial participant (though deemed unrelated by attending physician, development ceased as precautionary measure) Ipamorelin Phase II trials for postoperative ileus showed no significant efficacy versus placebo and were discontinued Long-term human safety profile completely unestablished beyond early-phase studies Optimal therapeutic dosing, treatment duration, and patient selection criteria unknown No published data on use in pediatric, geriatric, or medically complex populations Mechanistic Understanding Gaps Fundamental aspects of the peptide blends mechanisms require further elucidation: Disconnect between pharmacokinetics and pharmacodynamics peptides clear rapidly (hours) but effects persist for days

Born out of frustration with a market saturated by corner-cutting and profit-first mindsets, we set out to redefine what researchers should expect and deserve